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The subject of this editorial is the use of oxygen in emergency situations for patients with chronic respiratory disorders, many of whom may already be using home oxygen on a regular basis. This subject will be discussed according to the commoner categories of disease for which emergency home oxygen might be used and the circumstances in which oxygen might be used nonelectively.
Chronic obstructive pulmonary disease
There is good evidence that long-term oxygen therapy (LTOT) increases life expectancy in patients with severe hypoxaemic chronic obstructive pulmonary disease (COPD). 1 For this reason, LTOT is the largest category of home oxygen use in adults, often supplemented by ambulatory oxygen to allow patients to mobilize. Many patients with COPD who are not sufficiently hypoxaemic to require LTOT have been advised to use short-burst oxygen therapy in the hope and expectation that it would relieve breathlessness after exertion. Although this is not a medical emergency, it is the commonest nonelective use of oxygen for patients with COPD, and the National Health Service in the United Kingdom spends about 18 million pounds per year on this treatment. 2 Despite the widespread use of shortburst oxygen therapy in the United Kingdom, two systematic reviews have concluded that this form of oxygen use has no proven benefit in non-hypoxaemic patients with COPD, and the most recent (and largest) clinical trial has shown no benefit from short-burst oxygen therapy after exertion for patients with severe COPD, even among patients who desaturate on exertion. [3] [4] [5] The advice in the National Institute for Clinical Excellence COPD guideline is that short-burst oxygen therapy should only be considered for episodes of severe breathlessness in patients with COPD not relieved by other treatments and only if an improvement in breathlessness following therapy has been documented. 6 Patients with COPD of sufficient severity to require LTOT are at risk of acute exacerbations of COPD with worsening hypoxaemia. These patients are especially likely to be vulnerable to type 2 respiratory failure (hypercapnia) if high concentrations of oxygen are given. 6, 7 Hypercapnic respiratory failure can lead to increased risk of requirement for mechanical ventilation and increased risk of death when excessive oxygen is administered. [6] [7] [8] [9] Therefore, it is advisable for patients in this situation to call for medical assistance rather than simply turning up the flow rate of oxygen in the home environment. The British Thoracic Society guideline for emergency oxygen therapy recommends an oxygen saturation target range of 88-92% for most such patients although some patients may require a lower target range based on previous blood gas analysis. 10 Most patients in this situation will require urgent transport to hospital where blood gases can be sampled and controlled oxygen therapy can be given. Patients with prior episodes of hypercapnic respiratory failure may be provided with an oxygen alert card and a personal 24% or 28% Venturi mask to ensure that they are not exposed to the risks of hyperoxic hypercapnia during ambulance transfers to hospital. 10 Patients with severe hypoxaemia associated with hypercapnia and acidosis are likely to require treatment with noninvasive ventilation. 6 
Asthma
The vast majority of patients with asthma will never require oxygen therapy unless they require an emergency hospital admission due to a severe exacerbation of asthma. However, there are a small number of patients with brittle asthma who have repeated severe
Manchester Academic Health Science Centre, University of Manchester, Salford Royal University Hospital, Salford, UK exacerbations, and some clinicians provide such patients with an oxygen cylinder to have at home for emergency use to provide supplementary oxygen while awaiting the arrival of an emergency ambulance and also to allow emergency nebulized bronchodilators to be driven by oxygen rather than air. Patients with asthma of this severity are likely to be cared for in regional or sub-regional difficult asthma clinics, and this use of emergency oxygen should only be undertaken as part of a written asthma management plan which includes a call for urgent medical assistant in circumstances where emergency oxygen is required.
Lung cancer and other palliative care settings
Many patients with lung cancer who develop acute hypoxaemia have a treatable acute condition such as a large pleural effusion, bronchospasm, pneumonia, or airway obstruction by tumour. Although oxygen may be required in the emergency treatment of these patients, all of these conditions require specific treatments which will usually avoid the need for mediumterm oxygen treatment or LTOT.
Although oxygen was widely prescribed for the relief of breathlessness in patients with advanced cancer and for other palliative care indications, recent trials have shown that oxygen treatment is not superior to air treatment in non-hypoxaemic palliative care patients although there may be some benefit from oxygen administration when breathlessness is associated with hypoxaemia. 11, 12 As with COPD, there is no supportive evidence for the use of short-burst oxygen therapy in patients with advanced malignancy and breathlessness in the absence of hypoxaemia. Episodes of acute hypoxaemia may be due to an acute problem such as pneumonia or pleural effusion as discussed above and will require careful medical evaluation. Emergency oxygen therapy by the first responder team will be required if the patient is hypoxaemic. The recommended saturation range is 94-98% for most patients with acute hypoxaemia but 88-92% for those with significant underlying COPD. 10 Patients with chronic heart failure are often prescribed home oxygen therapy because of intractable breathlessness or to use during episodes of increased breathlessness, but a recent review of this topic concluded that LTOT should not be prescribed routinely to patients with chronic heart failure because no evidence exists that it reduces breathlessness or the frequency of clinical events such as admission to hospital or mortality. 13 The issue of self-administered emergency oxygen for exacerbations of heart failure at home has not been evaluated in any clinical trial and is not recommended. Patients with acute hypoxaemia due to exacerbated heart failure are likely to require careful medical evaluation and will usually require hospital admission.
Interstitial lung disease
Interstitial lung diseases such as idiopathic pulmonary fibrosis tend to progress slowly with median survival of 3 years from the time of diagnosis.
14 Patients with moderate disease may be normoxaemic at rest but hypoxaemic after minor exertion, and patients with advanced disease may be hypoxaemic at rest requiring LTOT, often supplemented with ambulatory oxygen therapy when they mobilize inside and outside the home. 14, 15 For these patients, unlike COPD patients, there is minimal risk of hypercapnic (type 2) respiratory failure so it is reasonable for patients or first responders to increase the flow rate or concentration of oxygen during emergencies or exacerbations to try and achieve a target saturation 10 range of 94-98%. Most such exacerbations are likely to require transfer for hospital or hospice care. The British Thoracic Society Interstitial Lung Disease Guideline recommends symptomatic use of oxygen for breathlessness (short-burst oxygen therapy) for selected patients with interstitial lung disease but acknowledges that there have been no clinical trials to support this practice. 14 
Neuromuscular disorders and skeletal disorders causing respiratory failure
Patients with chronic hypoxaemia due to skeletal or neuromuscular disorders are likely to require noninvasive ventilation at home rather than simple LTOT. 16 They are also at risk of hypercapnic respiratory failure if high-dose oxygen is given so the recommended 10 target saturation range during acute deterioration of such conditions is 88-92%. Most such exacerbations will require hospital admission for full clinical assessment and blood gas sampling. The patient's own ventilator should be used during ambulance transfers.
Cystic fibrosis
Patients with advanced cystic fibrosis may suffer from exacerbations which are similar to exacerbations of advanced COPD with associated hypoxaemia and hypercapnia, and emergency management should be along similar lines to the management of exacerbated COPD with a target saturation range of 88-92% for most patients or a personalized target saturation range based on previous blood gas results and supplemented by an oxygen alert card. 10 Patients with significant acute illness will require discussion with the regional cystic fibrosis centre and probable admission to that unit. Noninvasive ventilation is of great value in severe cases. 17 
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